drugset / Trial / NCT07231900
Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients
RandomizedCrossoverTriple-blindTreatment
Summary
The study is designed to diminish intra-dialytic hypertension in chrnic hemodialysis patients suffering from metabolic acidosis (low bicarbonate levels). The intervention is a tab of 500 mg sodium bicarbonate twice a day for one month, vs. placebo.
Timeline
- Start
- 2025-11-10
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 500 mg | Oral |